Evaluation of PEG-L-asparaginase in asparagine suppression and anti-drug antibody development in healthy Beagle dogs: A multi-phase preclinical study.

MLA

Feenstra, L. R., et al. “Evaluation of PEG-L-Asparaginase in Asparagine Suppression and Anti-Drug Antibody Development in Healthy Beagle Dogs: A Multi-Phase Preclinical Study.” Veterinary Journal (London, England : 1997), vol. 286, Aug. 2022, p. 105854. EBSCOhost, https://doi.org/10.1016/j.tvjl.2022.105854.

APA

Feenstra, L. R., Gehring, R., van Geijswijk, I. M., König, T., Prinsen, H. C. M. T., Vandemeulebroecke, K., Lammens, T., Krupa, A., & Teske, E. (2022). Evaluation of PEG-L-asparaginase in asparagine suppression and anti-drug antibody development in healthy Beagle dogs: A multi-phase preclinical study. Veterinary Journal (London, England : 1997), 286, 105854. https://doi.org/10.1016/j.tvjl.2022.105854

Chicago

Feenstra, L R, R Gehring, I M van Geijswijk, T König, H C M T Prinsen, K Vandemeulebroecke, T Lammens, A Krupa, and E Teske. 2022. “Evaluation of PEG-L-Asparaginase in Asparagine Suppression and Anti-Drug Antibody Development in Healthy Beagle Dogs: A Multi-Phase Preclinical Study.” Veterinary Journal (London, England : 1997) 286 (August): 105854. doi:10.1016/j.tvjl.2022.105854.